TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $1,401,000 | +30.9% | 77,000 | +28.3% | 0.39% | -25.0% |
Q3 2020 | $1,070,000 | -0.6% | 60,000 | 0.0% | 0.52% | -29.9% |
Q2 2020 | $1,076,000 | +130.4% | 60,000 | +120.9% | 0.74% | +60.5% |
Q3 2019 | $467,000 | -80.7% | 27,163 | -80.1% | 0.46% | -57.1% |
Q2 2019 | $2,421,000 | -13.1% | 136,792 | 0.0% | 1.07% | -40.5% |
Q1 2019 | $2,786,000 | – | 136,792 | – | 1.80% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |